Navigation Links
Tobacco plant based Vaccine against Plague

Researchers from the Biodesign Institute, Arizona State University have successfully produced Plague vaccines from Tobacco plants. The researchers were able to produce vaccines from bioengineered // plant which is found to be effective against guinea pigs which were exposed to pneumonic plague bacterium. The researchers are to start a clinical trial of the new vaccine in human to study the efficacy of the new vaccine. The researchers have reported the results of this study n the Journal Proceedings of the National Academy of Sciences.

Plague is an infectious disease caused by the bacterium Yersinia pestis, transmission mostly occurs by transmission of bacterium from rodent flea bite or handling of infected animal. Pneumonic plague can occur by inhaling infected droplet containing the flea. WHO has reported an early outbreak of 1000-3000 plague cases every year. Plague causes painful swollen lymph node with fever and exhaustion. The infection is highly progressive and can lead to fatality if antibiotic treatment is started immediately after diagnosis.

Though natural plague bacterium have been effectively controlled there as been an increased threat of genetically modified resistant strains of Yersinia pestis produced as a bioweapon to cause bio terrorism. Scientists are not sure whether these antibiotics would work effectively against this mutated bacterium which has led to an increase need to produce vaccine against plague infection.

Researchers have produced Recombinant subunit vaccines against plague by using two plague antigens F1, V and a combination of these two antigens as it gives the option of producing the required antigen vaccines depending on the strain of the bacterium which causes the outbreak. By injecting the antigens in the plant the researchers were able to produce high quantity of stable antigens within 10 days of infecting the plant, when injecting on guinea pigs either intramuscular or subcutaneous the guinea pigs produced high levels of stable antigens which immunizes the body of the guinea pig with antibodies against the required strain of the bacterium and when challenged with a dosage of Yersinia pestis bacterium the guinea pig antibodies were found to counteract these bacterium and produce an effective immunity killing these bacterium.


'"/>




Related medicine news :

1. Tobacco chewing leads to dental caries
2. Tobacco and alcohol connected to larger health problems
3. Vegetables decrease Tobacco Toxins
4. Exposure To Tobacco Smoke Can Lead To Sickle Cell Crisis
5. Tobacco Found To Trigger Familial Pancreatic Cancer
6. Tobacco smoke increases the levels of Cox 2.
7. Aggressive Tobacco taxation policy can reduce cigarette smoking
8. Role Of Tobacco In Development Of Oral Cancer And Heart Disease
9. Women More Prone To Risk of Colorectal Cancer from Tobacco
10. WHO Intensifies Anti-Tobacco war
11. New Zealand Researchers Call For Tobacco-Free Society
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood Bank (TCBB), ... labor and delivery team at Women’s Hospital at Renaissance in Edinburg for their outstanding ... the hospital and decide to donate. , “Women’s Hospital at Renaissance has been ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and elimination ... safety and minimize the cost of development. In this webinar, sponsored by Molecular ... lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , In ...
(Date:4/28/2017)... ... ... Bill Howe started his sewer and drain company in 1980 focusing heavily ... team, the Bill Howe brand was born and they began cultivating their mission to ... the San Diego community in which they worked, lived and were raising their daughters. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... of ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled ... wearable activity and sleep monitoring solutions for the global scientific community. The company’s ...
(Date:4/28/2017)... ... 2017 , ... Intellitec Solutions announced the publication of a ... Dynamics GP solution that integrates to their PointClickCare EHR software package. With the ... Brooke Grove now has the capability to achieve its goal for a comprehensive ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... it will be participating in the Deutsche Bank Securities ... in Boston, Massachusetts on Wednesday, ... a.m. Eastern Time. A live webcast of ... Relations website at http://investor.zimmerbiomet.com .  The webcast will ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
Breaking Medicine Technology: